1. Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use, US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, February 28, 1997.
2. Stability of Protein Pharmaceuticals: Part A, Chemical and Physical pathways of Protein Degradation;Clarke,1992
3. Deamidation: a source of microheterogeneity in pharmaceutical proteins